Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$26.42−1.33 (-4.79%)
Close on Nov 18, 2026Market cap $1.72BP/E –Yield –
Zenas BioPharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zenas BioPharma's price to sales ratio was 105.3× on Apr 30, 2026, against 96.8× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 105.3× | +3.1 |
| 2025 | Dec 31, 2025 | 102.2× | – |
See a number that looks wrong?